J Gen Virol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 71 (1990), 681-687; DOI 10.1099/0022-1317-71-3-681
© 1990 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimeld, C.
Right arrow Articles by Easty, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimeld, C.
Right arrow Articles by Easty, D. L.
Agricola
Right arrow Articles by Shimeld, C.
Right arrow Articles by Easty, D. L.

Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system

C. Shimeld1, T. J. Hill2, W. A. Blyth2 and D. L. Easty1

1 Department of Ophthalmology
and2 Department of Microbiology, The Medical School, University Walk, Bristol BS8 1TD, U.K.

Mice were treated with serum containing antibodies to herpes simplex virus type 1 (HSV-1) or normal serum, 1 day before inoculation on the cornea with HSV-1 strain McKrae. As expected, without passive immunization, mice developed high levels of serum neutralizing antibody. By contrast, in passively immunized animals, such antibody became undetectable by 29 days after inoculation of serum, in spite of the virus infection. There was no difference between passively immunized mice and those given normal serum in the duration of shedding of virus in tears and the duration and severity of corneal epithelial disease. However, non-immunized mice had a high incidence of mortality and developed disease of the iris, corneal stroma and lids, and their corneas became opaque and vascularized. In non-immunized animals, the timing of isolation of virus from nervous tissues and the sequence of appearance of virus antigens in ocular tissues indicate that the disease of deeper eye tissue was caused by virus spreading from the nervous system back to the eye. Restriction of such spread in passively immunized animals seems the likely explanation for their protection from death and severe ocular damage. Despite this restricted spread, passively immunized animals had a high incidence of latent infection in the ophthalmic part of the trigeminal ganglion. However, in comparison with mice given normal serum, there was a far lower incidence of such infection in the other two parts of this ganglion and in the superior cervical ganglion. Since passively immunized animals have a high incidence of latent infection in the ophthalmic part of the trigeminal ganglion and their eyes are normal, they will prove useful in studies involving induction of recurrent disease.

Received 6 July 1989; accepted 7 November 1989.


This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
P. M. Stuart, B. Summers, J. E. Morris, L. A. Morrison, and D. A. Leib
CD8+ T cells control corneal disease following ocular infection with herpes simplex virus type 1
J. Gen. Virol., July 1, 2004; 85(7): 2055 - 2063.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Verschoor, M. A. Brockman, M. Gadjeva, D. M. Knipe, and M. C. Carroll
Myeloid C3 Determines Induction of Humoral Responses to Peripheral Herpes Simplex Virus Infection
J. Immunol., November 15, 2003; 171(10): 5363 - 5371.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. M. Richards, R. Case, T. R. Hirst, T. J. Hill, and N. A. Williams
Protection against Recurrent Ocular Herpes Simplex Virus Type 1 Disease after Therapeutic Vaccination of Latently Infected Mice
J. Virol., June 15, 2003; 77(12): 6692 - 6699.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
N. Bourne, R. B. Pyles, D. I. Bernstein, and L. R. Stanberry
Modification of primary and recurrent genital herpes in guinea pigs by passive immunization
J. Gen. Virol., November 1, 2002; 83(11): 2797 - 2801.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
T. L. Keadle, K. A. Laycock, J. L. Morris, D. A. Leib, L. A. Morrison, J. S. Pepose, and P. M. Stuart
Therapeutic vaccination with vhs- herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice
J. Gen. Virol., October 1, 2002; 83(10): 2361 - 2365.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
T. H. Stumpf, R. Case, C. Shimeld, D. L. Easty, and T. J. Hill
Primary herpes simplex virus type 1 infection of the eye triggers similar immune responses in the cornea and the skin of the eyelids
J. Gen. Virol., June 1, 2002; 83(7): 1579 - 1590.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. L. Keadle, L. A. Morrison, J. L. Morris, J. S. Pepose, and P. M. Stuart
Therapeutic Immunization with a Virion Host Shutoff-Defective, Replication-Incompetent Herpes Simplex Virus Type 1 Strain Limits Recurrent Herpetic Ocular Infection
J. Virol., April 15, 2002; 76(8): 3615 - 3625.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Verschoor, M. A. Brockman, D. M. Knipe, and M. C. Carroll
Cutting Edge: Myeloid Complement C3 Enhances the Humoral Response To Peripheral Viral Infection
J. Immunol., September 1, 2001; 167(5): 2446 - 2451.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Shimeld, S. Efstathiou, and T. Hill
Tracking the Spread of a lacZ-Tagged Herpes Simplex Virus Type 1 between the Eye and the Nervous System of the Mouse: Comparison of Primary and Recurrent Infection
J. Virol., June 1, 2001; 75(11): 5252 - 5262.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. P. Deshpande, S. Lee, M. Zheng, B. Song, D. Knipe, J. A. Kapp, and B. T. Rouse
Herpes Simplex Virus-Induced Keratitis: Evaluation of the Role of Molecular Mimicry in Lesion Pathogenesis
J. Virol., April 1, 2001; 75(7): 3077 - 3088.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. P. Deshpande, M. Zheng, M. Daheshia, and B. T. Rouse
Pathogenesis of Herpes Simplex Virus-Induced Ocular Immunoinflammatory Lesions in B-Cell-Deficient Mice
J. Virol., April 15, 2000; 74(8): 3517 - 3524.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Shimeld, D. L. Easty, and T. J. Hill
Reactivation of Herpes Simplex Virus Type 1 in the Mouse Trigeminal Ganglion: an In Vivo Study of Virus Antigen and Cytokines
J. Virol., March 1, 1999; 73(3): 1767 - 1773.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. N. Milligan, D. I. Bernstein, and N. Bourne
T Lymphocytes Are Required for Protection of the Vaginal Mucosae and Sensory Ganglia of Immune Mice Against Reinfection with Herpes Simplex Virus Type 2
J. Immunol., June 15, 1998; 160(12): 6093 - 6100.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. A. Padgett, J. F. Sheridan, J. Dorne, G. G. Berntson, J. Candelora, and R. Glaser
Social stress and the reactivation of latent herpes simplex virus type 1
PNAS, June 9, 1998; 95(12): 7231 - 7235.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
A Sharma and C Shimeld
In vivo immunofluorescence to diagnose herpes simplex virus keratitis in mice
Br J Ophthalmol, September 1, 1997; 81(9): 785 - 788.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1990 by the Society for General Microbiology.